1. Home
  2. NBY vs BGB Comparison

NBY vs BGB Comparison

Compare NBY & BGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

SELL

Current Price

$5.35

Market Cap

398.2M

Sector

N/A

ML Signal

SELL

Logo Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

BGB

Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

HOLD

Current Price

$11.82

Market Cap

525.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBY
BGB
Founded
2000
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
398.2M
525.7M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
NBY
BGB
Price
$5.35
$11.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.2M
154.6K
Earning Date
11-07-2025
01-01-0001
Dividend Yield
N/A
9.75%
EPS Growth
N/A
N/A
EPS
0.47
N/A
Revenue
$10,302,000.00
N/A
Revenue This Year
$23.91
N/A
Revenue Next Year
$32.05
N/A
P/E Ratio
$205.94
N/A
Revenue Growth
390.34
N/A
52 Week Low
$0.46
$10.40
52 Week High
$6.47
$11.97

Technical Indicators

Market Signals
Indicator
NBY
BGB
Relative Strength Index (RSI) 84.30 46.68
Support Level $2.92 $11.74
Resistance Level $1.11 $11.90
Average True Range (ATR) 0.71 0.10
MACD 0.30 -0.01
Stochastic Oscillator 77.05 26.92

Price Performance

Historical Comparison
NBY
BGB

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About BGB Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

Blackstone Strategic Credit Fund is a closed-end term fund. Its primary investment objective is to seek high current income. The secondary objective of the fund is to seek the preservation of capital. Under normal market conditions, the Fund invests at least 80% of its Managed Assets in senior, secured floating-rate loans. The fund also invest in second-lien loans and high yield bonds and employs financial leverage, which may increase risk to the Fund. The Fund has a limited term and absent shareholder approval to extend the life of the Fund.

Share on Social Networks: